An IL6 variant -174 G-C alters cardiac hypertrophy but not cardiometabolic responses to HFD in mice
Authors:
- LE WatsonLWLE Watson
- Rf D’SOuzaRDRf D’SOuza
Open Access
- 23 March 2026
- journal article
- Published by Springer Nature in npj Metabolic Health and Disease
- Vol. 4 (1)
Abstract
Chronic elevations in interleukin-6 (IL6) signaling have been shown to exacerbate features of cardiometabolic disease. A common variant in the IL6 promoter (location -174 G/C, identifier rs1800795) is associated with increased circulating IL6, and increased cardiometabolic disease incidence in some populations. This study’s objective was to isolate the impact of this gene variant on cardiometabolic responses to metabolic stress, using knock-in mice with a GG wildtype or variant CC genotype for the murine homolog of rs1800795. Male and female IL6 variant CC mice on a high fat diet exhibited enhanced systemic IL6 levels but similar weight gain, energy expenditure, adipose tissue inflammation, glucose homeostasis, and cardiac function relative to control GG mice. Sex differences in the effect of the IL6 variant on cardiomyocyte dimensions were observed, with male variant mice exhibiting smaller cardiomyocyte volume, and female variant mice exhibiting larger cardiomyocyte volume with smaller raw heart mass relative to control GG mice. These findings suggest that, in a controlled experimental setting, the IL6 promoter variant (−174 G/C) does not increase susceptibility to cardiometabolic disease. Further work is required to understand the mechanistic link between this IL6 variant and associated increased cardiometabolic risk observed in population studies.Keywords
Funding Information
- Rutherford Discovery Fellowship
This publication has 44 references indexed in Scilit:
- Interleukin‐6 and Interleukin‐8 Gene Expressions Differ Between Male and Female Patients at Time of Hip Arthroscopy for Femoroacetabular Impingement SyndromeArthroscopy, Sports Medicine, and Rehabilitation, 2024
- Association of interleukin 6 -174 G/C polymorphism with coronary artery disease and circulating IL-6 levels: a systematic review and meta-analysisInflammation Research, 2021
- Genome‐Wide Maps of Transcription Regulatory Elements and Transcription Enhancers in Development and DiseaseComprehensive Physiology, 2019
- High-fat diet induces cardiomyocyte apoptosis via the inhibition of autophagyEuropean Journal of Nutrition, 2015
- The varying faces of IL-6: From cardiac protection to cardiac failureCytokine, 2015
- Blocking IL-6 trans-Signaling Prevents High-Fat Diet-Induced Adipose Tissue Macrophage Recruitment but Does Not Improve Insulin ResistanceCell Metabolism, 2015
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF ExpressionCell, 2010
- Interleukin-6–174 G>C polymorphism affects the association between IL-6 plasma levels and insulin resistance in type 2 diabetic patientsDiabetes Research and Clinical Practice, 2006
- SECRETION OF IL-6, IL-11 AND LIF BY HUMAN CARDIOMYOCYTES IN PRIMARY CULTURECytokine, 2002
- Relationship Between Interleukin 6 and Mortality in Patients With Unstable Coronary Artery DiseaseJAMA, 2001